Short description
InterCure is a medical device company focused on respiratory treatment that has developed and patented a technology platform.
Description
InterCure is a medical device company that has developed and patented a technology platform for respiratory-based treatment of cardiovascular and pulmonary diseases.
The Company has incorporated its "Interactive Respiratory-Pacing" technology platform into several product lines, the first two of which offer a new therapeutic class of non-drug treatments for two of the most widespread and costly disease states in the healthcare industry: hypertension and heart failure.
InterCure’s first market-ready product, RESPeRATE, is the only FDA-cleared, medical device clinically proven to lower high blood pressure with no side effects.
InterCure's heart failure product, InTone™ has successfully completed phase 2a efficacy clinical trials and is expected to be launched when it completes the regulatory approval process.
With its outstanding management team, the board of directors and a world-class Scientific Advisory Board, Intercure is poised to become the market leader in patient-focused medical devices that provide non-drug, no-side-effect treatment for some of the world's most prevalent and costly chronic conditions.
InterCure was founded in 1994 and is headquartered in Ra'anana, Israel.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Ra'anana, HaMerkaz, Israel, Asia
Founded on
January 1, 1994
Exited on
October 27, 2011
Went public on
October 27, 2011
Stock symbol
INCR
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$56378 - 90123
Sign in for full access
Investors
No Way, Noway Youcantaccess, Absolutely Noaccess, Blurry Noaccess, Blurry Noaccess, No Way, Noaccess, Uh Ohhhh, Cannot Access, Blurry Noaccess, Noaccess, Absolutely Noaccess
Sign in for full access
Founders
Ali Mohamed laarbi
Funding rounds count
1
Portfolio organisations count
Blurry Noaccess, Noaccess
Sign in for full access
Lead investments count
1